Triple-negative breast cancer (TNBC), characterized by the absence of estrogen and progesterone receptors and lack of HER2 protein expression, represents one of the most aggressive and challenging subtypes of breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.